One of the core objectives of the ITC’s Method Development WG is to share optimized methodologies used for immune safety testing between companies and research organizations to assure appropriate preclinical data for public health safety. To ensure that the committee remains current on emerging methods and technologies in immune safety science the WG has organized a “ New Methods and Technologies Webinar Series”.
Dr. Adrian Roth, Principal Scientific Director at Roche, will give a talk titled “Novel Human Cell Models in Drug Development: How 3D, Organoids, and Organ on Chip Models can improve and renew current paths and our vision for the future” where he outlines how MPS may be applied in the immune safety space.
740 15th Street NW, Suite 600
Washington, DC 20005
Sign up for our monthly e-newsletter.